804 related articles for article (PubMed ID: 11034610)
1. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.
Serhan CN; Clish CB; Brannon J; Colgan SP; Chiang N; Gronert K
J Exp Med; 2000 Oct; 192(8):1197-204. PubMed ID: 11034610
[TBL] [Abstract][Full Text] [Related]
2. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938
[TBL] [Abstract][Full Text] [Related]
3. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
4. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.
Oh SF; Pillai PS; Recchiuti A; Yang R; Serhan CN
J Clin Invest; 2011 Feb; 121(2):569-81. PubMed ID: 21206090
[TBL] [Abstract][Full Text] [Related]
5. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).
Titos E; Chiang N; Serhan CN; Romano M; Gaya J; Pueyo G; Clària J
Am J Physiol; 1999 Nov; 277(5):C870-7. PubMed ID: 10564079
[TBL] [Abstract][Full Text] [Related]
6. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.
Clària J; Serhan CN
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9475-9. PubMed ID: 7568157
[TBL] [Abstract][Full Text] [Related]
7. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
Clària J; Lee MH; Serhan CN
Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.
Pouliot M; Clish CB; Petasis NA; Van Dyke TE; Serhan CN
Biochemistry; 2000 Apr; 39(16):4761-8. PubMed ID: 10769133
[TBL] [Abstract][Full Text] [Related]
9. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.
Serhan CN; Oliw E
J Clin Invest; 2001 Jun; 107(12):1481-9. PubMed ID: 11413151
[No Abstract] [Full Text] [Related]
10. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.
Serhan CN; Hong S; Gronert K; Colgan SP; Devchand PR; Mirick G; Moussignac RL
J Exp Med; 2002 Oct; 196(8):1025-37. PubMed ID: 12391014
[TBL] [Abstract][Full Text] [Related]
11. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.
Clish CB; O'Brien JA; Gronert K; Stahl GL; Petasis NA; Serhan CN
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8247-52. PubMed ID: 10393980
[TBL] [Abstract][Full Text] [Related]
12. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
13. Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor.
Chen LY; Lawson DL; Mehta JL
Thromb Res; 1994 Nov; 76(4):317-22. PubMed ID: 7871491
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 Fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment.
Tull SP; Yates CM; Maskrey BH; O'Donnell VB; Madden J; Grimble RF; Calder PC; Nash GB; Rainger GE
PLoS Biol; 2009 Aug; 7(8):e1000177. PubMed ID: 19707265
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
16. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.
Chiang N; Bermudez EA; Ridker PM; Hurwitz S; Serhan CN
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15178-83. PubMed ID: 15471991
[TBL] [Abstract][Full Text] [Related]
17. Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer.
Janakiram NB; Rao CV
Curr Mol Med; 2009 Jun; 9(5):565-79. PubMed ID: 19601807
[TBL] [Abstract][Full Text] [Related]
18. Interaction of PGH synthase isozymes-1 and -2 with nonsteroidal anti-inflammatory drugs.
Smith WL; Meade EA; Dewitt DL
Adv Exp Med Biol; 1997; 400A():189-96. PubMed ID: 9547557
[No Abstract] [Full Text] [Related]
19. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
Gronert K; Gewirtz A; Madara JL; Serhan CN
J Exp Med; 1998 Apr; 187(8):1285-94. PubMed ID: 9547339
[TBL] [Abstract][Full Text] [Related]
20. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
Serhan CN
Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
